Consenso para la nomenclatura en Química de Radiofármacos
Recommended guidelines, assembled by an international and intersociety working group after extensive consultation with peers in the wider field of nuclear chemistry and radiopharmaceutical sciences.
Over recent years, within the community of radiopharmaceutical sciences, there
has been an increased incidence of incorrect usage of established scientific terms
and conventions, and even the emergence of ‘self-invented’ terms. In order to
address these concerns, an international Working Group on ‘Nomenclature in
Radiopharmaceutical Chemistry and related areas’ was established in 2015 to
achieve clarification of terms and to generate consensus on the utilisation of a
standardised nomenclature pertinent to the field.
Upon open consultation, the following consensus guidelines were agreed, which
– Provide a reference source for nomenclature good practice in the radiopharmaceutical
– Clarify the use of terms and rules concerning exclusively radiopharmaceutical
terminology, i.e. nuclear- and radiochemical terms, symbols and expressions.
– Address gaps and inconsistencies in existing radiochemistry nomenclature rules.
– Provide source literature for further harmonisation beyond our immediate peer
group (publishers, editors, IUPAC, pharmacopoeias, etc.).